New drug pricing policy squeezing drug firms

The government’s plan to cut drug prices by an average of 14 percent starting April has triggered vehement protests from the domestic pharmaceutical community.

A report released by the Korea Pharmaceutical Manufacturers Association forecast that the scheme would reduce the industry’s annual sales revenue by 2.1 trillion won, given the imminent large price cuts.

On top of that, the report...